Bio-Works Technologies AB (publ) (FRA:1BD)
Germany flag Germany · Delayed Price · Currency is EUR
0.2730
-0.0470 (-14.69%)
Last updated: Feb 23, 2026, 8:21 AM CET

Bio-Works Technologies AB Balance Sheet

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
34.9334.2839.3865.88102.75
Cash & Short-Term Investments
34.9334.2839.3865.88102.75
Cash Growth
1.91%-12.96%-40.22%-35.88%210.80%
Accounts Receivable
12.692.197.157.94.66
Other Receivables
3.032.6523.972.18
Receivables
15.734.849.1611.886.84
Inventory
15.6410.069.079.677.85
Prepaid Expenses
2.741.341.491.331.1
Other Current Assets
-0.160.570.430.54
Total Current Assets
69.0550.6859.6689.18119.08
Property, Plant & Equipment
1.711.822.492.431.78
Other Long-Term Assets
-0---
Total Assets
70.7652.562.1591.61120.86
Accounts Payable
4.092.528.336.83.12
Accrued Expenses
6.322.895.374.734.83
Current Income Taxes Payable
--2.24-0.05
Other Current Liabilities
11.142.52.1812.394.35
Total Current Liabilities
21.557.9118.1223.9212.35
Other Long-Term Liabilities
-0---
Total Liabilities
21.557.9118.1223.9212.35
Common Stock
9.827.83.93.523.49
Additional Paid-In Capital
397.81379.75345.89313.01309
Retained Earnings
-358.42-342.96-305.76-248.84-203.98
Comprehensive Income & Other
-0---0
Shareholders' Equity
49.2144.5844.0367.69108.51
Total Liabilities & Equity
70.7652.562.1591.61120.86
Net Cash (Debt)
34.9334.2839.3865.88102.75
Net Cash Growth
1.91%-12.96%-40.22%-35.88%210.80%
Net Cash Per Share
0.420.691.091.883.29
Filing Date Shares Outstanding
98.2377.9638.9835.1634.87
Total Common Shares Outstanding
98.2377.9638.9835.1634.87
Working Capital
47.542.7741.5465.26106.73
Book Value Per Share
0.500.571.131.933.11
Tangible Book Value
49.2144.5844.0367.69108.51
Tangible Book Value Per Share
0.500.571.131.933.11
Machinery
-4.434.595.324.2
Source: S&P Global Market Intelligence. Standard template. Financial Sources.